Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and outcome of high on-treatment platelet reactivity in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] study).
Saia F, Marino M, Campo G, Valgimigli M, Guastaroba P, Taglieri N, Tondi S, Manari A, Guiducci V, Sangiorgio P, Varani E, Magnavacchi P, De Palma R, Marzocchi A. Saia F, et al. Among authors: marzocchi a. Am J Cardiol. 2013 Sep 15;112(6):792-8. doi: 10.1016/j.amjcard.2013.05.010. Epub 2013 Jun 5. Am J Cardiol. 2013. PMID: 23747044 Clinical Trial.
Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events.
Marzocchi A, Piovaccari G, Manari A, Aurier E, Benassi A, Saia F, Casella G, Varani E, Santarelli A, Guastaroba P, Grilli R, Maresta A. Marzocchi A, et al. Am J Cardiol. 2005 Jun 15;95(12):1409-14. doi: 10.1016/j.amjcard.2005.01.096. Am J Cardiol. 2005. PMID: 15950561
Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry.
Saia F, Piovaccari G, Manari A, Santarelli A, Benassi A, Aurier E, Sangiorgio P, Tarantino F, Geraci G, Vecchi G, Guastaroba P, Grilli R, Marzocchi A. Saia F, et al. Among authors: marzocchi a. J Am Coll Cardiol. 2006 Oct 3;48(7):1312-8. doi: 10.1016/j.jacc.2006.03.063. Epub 2006 Sep 14. J Am Coll Cardiol. 2006. PMID: 17010788 Free article.
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Baldazzi F, Silenzi S, Taglieri N, Bacchi-Reggiani ML, Gordini G, Guastaroba P, Grilli R, Branzi A. Ortolani P, et al. Among authors: marzocchi a. Am J Cardiol. 2007 Sep 1;100(5):787-92. doi: 10.1016/j.amjcard.2007.03.099. Epub 2007 Jun 13. Am J Cardiol. 2007. PMID: 17719321
Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
Marzocchi A, Manari A, Piovaccari G, Marrozzini C, Marra S, Magnavacchi P, Sangiorgio P, Marinucci L, Taglieri N, Gordini G, Binetti N, Guiducci V, Franco N, Reggiani ML, Saia F; FATA Investigators. Marzocchi A, et al. Eur Heart J. 2008 Dec;29(24):2972-80. doi: 10.1093/eurheartj/ehn467. Epub 2008 Oct 21. Eur Heart J. 2008. PMID: 18940887 Clinical Trial.
Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A. Campo G, et al. Among authors: marzocchi a. Int J Cardiol. 2010 Apr 15;140(2):154-60. doi: 10.1016/j.ijcard.2008.11.021. Epub 2008 Dec 3. Int J Cardiol. 2010. PMID: 19056134
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
Taglieri N, Saia F, Guiducci V, Tondi S, Conrotto F, Marrozzini C, Rocchi G, Biagini E, Reggiani ML, Giacometti P, Piovaccari G, Manari A, Marzocchi A; FATA Trial Investigators. Taglieri N, et al. Among authors: marzocchi a. Am J Cardiol. 2009 Mar 15;103(6):785-90. doi: 10.1016/j.amjcard.2008.11.029. Epub 2009 Jan 21. Am J Cardiol. 2009. PMID: 19268732 Clinical Trial.
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry.
Saia F, Piovaccari G, Manari A, Guastaroba P, Vignali L, Varani E, Santarelli A, Benassi A, Liso A, Campo G, Tondi S, Tarantino F, De Palma R, Marzocchi A. Saia F, et al. Among authors: marzocchi a. EuroIntervention. 2009 May;5(1):57-66. doi: 10.4244/eijv5i1a10. EuroIntervention. 2009. PMID: 19577984
Long-term clinical outcomes after drug eluting stent implantation in women with de novo coronary lesions. Results from the REAL (REgistro Regionale AngiopLastiche Emilia-Romagna) multicenter registry.
Ortolani P, Solinas E, Guastaroba P, Casella G, Manari A, Piovaccari G, Balducelli M, Tondi S, Percoco G, Tarantino F, Passerini F, Rossi R, Vignali L, De Palma R, Grilli R, Marzocchi A. Ortolani P, et al. Among authors: marzocchi a. Int J Cardiol. 2011 May 19;149(1):55-62. doi: 10.1016/j.ijcard.2009.11.044. Epub 2010 Jan 8. Int J Cardiol. 2011. PMID: 20060183
231 results